Fernández-Vega Ophthalmological Institute, Surgery Department, School of Medicine, University of Oviedo, Oviedo, Spain.
J Cataract Refract Surg. 2011 Apr;37(4):706-13. doi: 10.1016/j.jcrs.2010.10.060.
To evaluate the efficacy, safety, and predictability of sequential implantation of Keraring intrastromal corneal ring segments (ICRS) and an Implantable Collamer Lens phakic intraocular lens (pIOL) with corneal relaxing incisions for refractive correction of keratoconus.
Fernández-Vega Ophthalmological Institute, Oviedo, Spain.
Cohort study.
This study comprised patients with keratoconus who had ICRS implantation followed 6 months later by pIOL implantation with corneal relaxing incisions. The uncorrected (UDVA) and corrected (CDVA) distance visual acuities and residual refractive errors, analyzed using vector analysis, were recorded preoperatively, 6 months after ICRS implantation, and 6 months after pIOL implantation.
The study enrolled 40 eyes (31 patients). The mean UDVA (decimal) was 0.11 Snellen ± 0.05 (SD) preoperatively, 0.18 ± 0.14 Snellen 6 months after ICRS implantation (P=.001), and 0.50 ± 0.27 Snellen 6 months after pIOL implantation (P<.0001). The mean CDVA was 0.56 ± 0.23 Snellen, 0.68 ± 0.25 Snellen, and 0.73 ± 0.20 Snellen, respectively (all P<.0001). Six months after pIOL implantation, the efficacy index was 0.88 and the safety index, 1.28. At 6 months, 65% of eyes were within ±1.00 diopter (D) of the desired refraction and 45% were within ±0.50 D. The mean spherical equivalent after pIOL implantation was -1.19 ± 1.33 D.
Sequential ICRS and pIOL implantation plus corneal relaxing incisions provided good visual and refractive outcomes, indicating that it is a predictable procedure for refractive correction of keratoconus.
No author has a financial or proprietary interest in any material or method mentioned.
评估角膜基质环段(ICRS)序贯植入联合角膜松解切口的可植入 Collamer 透镜(pIOL)治疗圆锥角膜的疗效、安全性和可预测性。
西班牙奥维耶多费尔南德斯-维加眼科研究所。
队列研究。
本研究纳入了接受 ICRS 植入术,6 个月后行角膜松解切口 pIOL 植入术的圆锥角膜患者。记录术前、ICRS 植入术后 6 个月和 pIOL 植入术后 6 个月的未矫正(UDVA)和矫正(CDVA)远视力以及残余屈光误差,采用矢量分析进行分析。
本研究共纳入 40 只眼(31 例患者)。术前 UDVA(十进制)平均为 0.11 视力表(Snellen)±0.05(标准差),ICRS 植入术后 6 个月为 0.18 ± 0.14 视力表,pIOL 植入术后 6 个月为 0.50 ± 0.27 视力表(均 P<.0001)。平均 CDVA 分别为 0.56 ± 0.23 视力表、0.68 ± 0.25 视力表和 0.73 ± 0.20 视力表(均 P<.0001)。pIOL 植入术后 6 个月,效能指数为 0.88,安全指数为 1.28。术后 6 个月,65%的眼屈光度在±1.00 屈光度(D)以内,45%的眼屈光度在±0.50 D 以内。pIOL 植入术后平均等效球镜为-1.19 ± 1.33 D。
ICRS 序贯植入联合 pIOL 植入联合角膜松解切口为圆锥角膜提供了良好的视力和屈光结果,表明这是一种可预测的治疗方法。